0001437749-21-009759.txt : 20210426
0001437749-21-009759.hdr.sgml : 20210426
20210426083258
ACCESSION NUMBER: 0001437749-21-009759
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171231
FILED AS OF DATE: 20210426
DATE AS OF CHANGE: 20210426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chaaban Bahige B.
CENTRAL INDEX KEY: 0001736938
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55557
FILM NUMBER: 21851664
MAIL ADDRESS:
STREET 1: 888 OLD TECUMSAH RD.
CITY: BELLE RIVER
STATE: A6
ZIP: N0R 1A0
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEN BIOTECH INC
CENTRAL INDEX KEY: 0001653821
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
BUSINESS PHONE: 226-344-0660
MAIL ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
5
1
rdgdoc.xml
FORM 5
X0306
5
2017-12-31
0
1
0001653821
CEN BIOTECH INC
CENBF
0001736938
Chaaban Bahige B.
300-3295 QUALITY WAY
WINDSOR, ONTARIO, CANADA
A6
N8T 3R9
ONTARIO, CANADA
1
1
1
Chief Executive Officer*
Common Stock
2017-11-30
4
A
0
L
8750000
0
A
8914793
D
Common Stock
2017-11-30
4
A
0
L
20000
0
A
8914793
D
8,770,000 shares of common stock of the issuer were granted by the issuer on November 30, 2017, pursuant to two restricted stock agreements pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors.
* The Reporting Person resigned as the Chief Executive Officer of the Issuer on July 12, 2017 and served as the President of the Issuer beginning on July 12, 2017, and served as the Interim Chief Executive Officer of the Issuer from November 13, 2019 until April 18, 2021 and was appointed as the Chief Executive Officer of the Issuer on April 19, 2021.
/s/ Bahige Chaaban
2021-04-26